Northern Trust’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-11,569
| Closed | -$41.4K | – | 4509 |
|
|
2023
Q2 | $41.4K | Hold |
11,569
| – | – | ﹤0.01% | 4260 |
|
|
2023
Q1 | $25.2K | Sell |
11,569
-263
| -2% | -$573 | ﹤0.01% | 4406 |
|
|
2022
Q4 | $142K | Sell |
11,832
-2,093
| -15% | -$25.2K | ﹤0.01% | 3991 |
|
|
2022
Q3 | $90K | Buy |
13,925
+285
| +2% | +$1.84K | ﹤0.01% | 4144 |
|
|
2022
Q2 | $62K | Sell |
13,640
-268,738
| -95% | -$1.22M | ﹤0.01% | 4342 |
|
|
2022
Q1 | $2.44M | Buy |
282,378
+39,253
| +16% | +$340K | ﹤0.01% | 3000 |
|
|
2021
Q4 | $3.47M | Buy |
243,125
+17,294
| +8% | +$247K | ﹤0.01% | 2924 |
|
|
2021
Q3 | $4.96M | Buy |
225,831
+14,749
| +7% | +$324K | ﹤0.01% | 2734 |
|
|
2021
Q2 | $2.82M | Buy |
+211,082
| New | +$2.82M | ﹤0.01% | 3187 |
|
|
2019
Q1 | – | Sell |
-18,269
| Closed | -$55K | – | 4255 |
|
|
2018
Q4 | $55K | Buy |
18,269
+259
| +1% | +$780 | ﹤0.01% | 4034 |
|
|
2018
Q3 | $88K | Buy |
+18,010
| New | +$88K | ﹤0.01% | 4051 |
|